| A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus (NCT05140824) | TJ Biopharma Co., Ltd. | 2021-12-30 |
| Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF (NCT04702256) | Assistance Publique - Hôpitaux de Paris | 2021-12-09 |
| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders (NCT05000216) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-13 |
| Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE) (NCT03975361) | Assistance Publique - Hôpitaux de Paris | 2021-04-29 |
| Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE (NCT04726553) | Oklahoma Medical Research Foundation | 2021-01-20 |
| Research Accelerated by You Lupus Registry (NCT06927219) | Lupus Foundation of America | 2020-10-01 |
| CCCR Lupus Patient Navigator Program (NCT04461158) | Medical University of South Carolina | 2020-09-03 |
| A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State (NCT04451772) | AbbVie | 2020-07-27 |
| A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (NCT03978520) | AbbVie | 2019-07-25 |
| Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients (NCT03656562) | Novartis Pharmaceuticals | 2018-12-19 |
| Omega-3 Replacement With Krill Oil in Disease Management of SLE (NCT03626311) | Aker BioMarine Human Ingredients AS | 2018-10-23 |
| EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study (NCT07281105) | Evergreen Therapeutics, Inc. | 2018-08-23 |
| CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid (NCT03492255) | University of Sao Paulo General Hospital | 2018-04-12 |
| Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases (NCT03122431) | University of Sao Paulo General Hospital | 2017-06-05 |
| Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE) (NCT02782039) | Assistance Publique - Hôpitaux de Paris | 2017-05-17 |
| Detection of Annexin A2 in Systemic Lupus Erythematosus (NCT03031925) | Centre Hospitalier Universitaire, Amiens | 2017-05-09 |
| A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE) (NCT03030976) | Shanghai GeneChem Co., Ltd. | 2017-03-01 |
| LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse (NCT02811094) | Assistance Publique Hopitaux De Marseille | 2016-11-09 |
| Acthar SLE (Systemic Lupus Erythematosus) (NCT02779153) | NYU Langone Health | 2016-10-01 |
| A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus (NCT02804763) | UCB Biopharma S.P.R.L. | 2016-06-02 |
| GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus (NCT01992666) | Hospices Civils de Lyon | 2013-10-01 |
| Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE) (NCT02006784) | Vanderbilt University | 2013-09-01 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases (NCT01151644) | University of Sao Paulo | 2010-04-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants (NCT05984251) | Amgen | 2009-12-21 |
| Auto-immunity in Lupus Patients After Influenza Vaccine (NCT01072734) | Assistance Publique - Hôpitaux de Paris | 2009-09-01 |
| An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) (NCT00960362) | Argos Therapeutics | 2009-07-01 |
| Prospective Study of Rapamycin for the Treatment of SLE (NCT00779194) | State University of New York - Upstate Medical University | 2008-10-01 |
| Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus (NCT00582881) | University of Miami | 2007-10-01 |
| Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients (NCT00608127) | Verto LTD | 2007-01-01 |